Logo image
Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes
Journal article   Open access   Peer reviewed

Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes

Bruce Bode, Roy W Beck, Dongyuan Xing, Lisa Gilliam, Irl Hirsch, Craig Kollman, Lori Laffel, Katrina J Ruedy, William V Tamborlane, Stuart Weinzimer, …
Diabetes care, Vol.32(11), pp.2047-2049
11/2009
DOI: 10.2337/dc09-0846
PMCID: PMC2768224
PMID: 19675193
url
https://doi.org/10.2337/dc09-0846View
Published (Version of record) Open Access

Abstract

To evaluate long-term effects of continuous glucose monitoring (CGM) in intensively treated adults with type 1 diabetes. We studied 83 of 86 individuals >or=25 years of age with type 1 diabetes who used CGM as part of a 6-month randomized clinical trial in a subsequent 6-month extension study. RESULTS After 12 months, median CGM use was 6.8 days per week. Mean change in A1C level from baseline to 12 months was -0.4 +/- 0.6% (P < 0.001) in subjects with baseline A1C >or=7.0%. A1C remained stable at 6.4% in those with baseline A1C <7.0%. The incidence rate of severe hypoglycemia was 21.8 and 7.1 events per 100 person-years in the first and last 6 months, respectively. Time per day with glucose levels in the range of 71-180 mg/dl increased significantly (P = 0.02) from baseline to 12 months. In intensively treated adults with type 1 diabetes, CGM use and benefit can be sustained for 12 months.
Hypoglycemia - diagnosis Hypoglycemia - epidemiology Body Weight Blood Glucose - analysis Monitoring, Ambulatory - methods Glycated Hemoglobin A - metabolism Humans Hypoglycemia - prevention & control Hyperglycemia - blood Hyperglycemia - diagnosis Motivation Time Factors Diabetes Mellitus, Type 1 - blood Adult Hypoglycemia - blood Blood Glucose - metabolism Diabetes Mellitus, Type 1 - psychology

Details

Metrics

Logo image